BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28801922)

  • 1. Prophylaxis with enoxaparin for prevention of venous thromboembolism after lung transplantation: a retrospective study.
    Sáez-Giménez B; Berastegui C; Sintes H; Perez-Miranda J; Figueredo A; López Meseguer M; Monforte V; Bravo C; Santamaría A; Ramon MA; Gómez-Ollés S; Roman A
    Transpl Int; 2017 Dec; 30(12):1266-1274. PubMed ID: 28801922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
    Carbajal-Mamani SL; Dideban B; Schweer D; Balavage KT; Chuang L; Wang Y; Wang S; Lee JH; Amaro B; Cardenas-Goicoechea J
    J Robot Surg; 2021 Jun; 15(3):343-348. PubMed ID: 32592139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis in gynecologic cancer surgery: Is extended prophylaxis with low molecular weight heparin justified?
    Marques de Marino P; Rial Horcajo R; Garcia Grandal T; Sanchez Hervas L; Serrano Hernando FJ; Herraiz Martinez MA; Coronado Martin PJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():90-95. PubMed ID: 30245443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy.
    Corona LE; Singhal U; Hafez K; Herrel LA; Kaffenberger SD; Montgomery JS; Morgan TM; Weizer AZ; Qin Y; Ambani SN
    Urol Oncol; 2020 Oct; 38(10):797.e1-797.e6. PubMed ID: 32624425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure.
    Mebazaa A; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Merli G; Schellong SW; Spyropoulos AC; Tapson VF; De Sanctis Y; Cohen AT
    Circulation; 2014 Jul; 130(5):410-8. PubMed ID: 24970782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One Size Does Not Fit All: Venous Thromboembolism Prophylaxis in Colorectal Cancer.
    Perrotti G; Sadri L; Fassler M; Sharma D; Kim S; Zebley M; Fassler S
    JSLS; 2020; 24(3):. PubMed ID: 32831542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.
    Hachey KJ; Sterbling H; Choi DS; Pinjic E; Hewes PD; Munoz J; McAneny D; Tripodis Y; Fernando HC; Litle VR
    J Am Coll Surg; 2016 Jun; 222(6):1019-27. PubMed ID: 26775163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
    Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
    J Med Econ; 2011; 14(6):824-34. PubMed ID: 22023098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of a Biosimilar Versus Branded Enoxaparin in the Prevention of Venous Thromboembolism Following Major Abdominal Surgery: A Randomized, Prospective, Single-Blinded, Multicenter Clinical Trial.
    Ramacciotti E; Ferreira U; Costa AJV; Raymundo SRO; Correa JA; Neto SG; Osvaldt AB; Agati L; Aguiar VCR; Davila R; Caltabiano TB; Magella FM; Volpiani GG; Castelli V; Caffaro RA; DalAcqua LZ; Matheus WE; Sato DY; Russeff GJDS; de Souza DG; Pazetto LE; de Lima TAM; Colnago EMDS; Fugii EY; Mussalem JS; Assao VT; Toffoletto O; Rodrigues DG; Afiune JB; Araujo GR
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1208-1215. PubMed ID: 30021463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A single-center experience of venous thromboembolism after adult lung transplantation].
    Zhao L; Wang C; Chen JY; Liang CY; Guo LJ; Li M; Chen WH
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Sep; 42(9):694-699. PubMed ID: 31484244
    [No Abstract]   [Full Text] [Related]  

  • 13. Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
    Arbetter DF; Jain P; Yee MK; Michalak N; Hernandez AF; Hull RD; Goldhaber SZ; Harrington RA; Gold A; Cohen AT; Gibson CM
    Pharm Stat; 2017 Nov; 16(6):445-450. PubMed ID: 28840662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two pharmacological prophylaxis strategies for venous thromboembolism in spinal cord injury patients: a retrospective study.
    de Almeida RL; Rodrigues CC; Melo E Silva CA; Beraldo PSS; Amado VM
    Spinal Cord; 2019 Oct; 57(10):890-896. PubMed ID: 31101899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy.
    Schomburg J; Krishna S; Soubra A; Cotter K; Fan Y; Brown G; Konety B
    Urol Oncol; 2018 Feb; 36(2):77.e9-77.e13. PubMed ID: 29097086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study.
    Cohen AT; Harrington R; Goldhaber SZ; Hull R; Gibson CM; Hernandez AF; Kitt MM; Lorenz TJ
    Am Heart J; 2014 Mar; 167(3):335-41. PubMed ID: 24576517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital-based costs associated with venous thromboembolism prophylaxis regimens.
    Merli G; Ferrufino CP; Lin J; Hussein M; Battleman D
    J Thromb Thrombolysis; 2010 May; 29(4):449-58. PubMed ID: 19847624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
    Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
    J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients.
    Pannucci CJ; Dreszer G; Wachtman CF; Bailey SH; Portschy PR; Hamill JB; Hume KM; Hoxworth RE; Rubin JP; Kalliainen LK; Pusic AL; Wilkins EG
    Plast Reconstr Surg; 2011 Nov; 128(5):1093-1103. PubMed ID: 22030491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.